Abstract:Ultrasensitive and accurate monitoring of ultralow-level biomarkers is imperiously needed in clinical diagnosis. So far, exploring high-performance photocathodes and developing new sensing strategies have remained central challenges in photoelectrochemical bioassays. Herein, a two-dimensional (2D) pyrene covalent organic framework (COF, PAF-130) is exemplified for the first time as a high-performance photocathode for precise immunosensing of α-synuclein (α-Syn) by integrating a DNAzyme-induced signal cycle amplification strategy with Ag nanoparticles (NPs)-mediated liposomal immunoassay. Through sequential immunobinding, lysis treatment, and acidolysis, numerous Ag+ ions are released, and then they activate the DNAzyme, which further recycles the cleavage of hairpin DNA (HDNA) on the photoelectrode and induces signal cycle amplification. As a result, an ultralow detection limit (3.6 fg/mL) and a wide linear range (10–5–103 ng/mL) are achieved, which surpass those of most methods reported so far. The proposed sensing approach can be readily extended to detect various biomarkers by substituting the biorecognition events, providing great promise for biomedical and related applications.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.1c01789?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.1c01789</a>.Materials and reagents; apparatus; experimental section; PXRD patterns of PAF-130 (Figure S1); simulated eclipsed crystal structures (Figure S2); PXRD patterns, TEM image, and high-resolution XPS spectra of C 1s and N 1s of g-C3N4 (Figure S3); TR-PL decay spectra of PAF-130 and PAF-130/g-C3N4 (Figure S4); effect of the proportion of g-C3N4 and PAF-130 on the photocurrent of PAF-130/g-C3N4 (Figure S5); optimization of the incubation time of the target and Ab2-ALL, the concentration of HDNA and the reaction time of Ag-DNAzyme during the fabrication of the sensor (Figure S6); long-term storage stability of the proposed sensor (Figure S7); performance comparison with other reported methods (Table S1); intraday and inter-day precision values of the sensor (Table S2); and data of human serum analysis (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.1c01789/suppl_file/ac1c01789_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Simple, rapid and sensitive detection of Parkinson's disease related alpha-synuclein using a DNA aptamer assisted liquid crystal biosensor

A Novel, Label-Free Liquid Crystal Biosensor for Parkinson's Disease Related Alpha-Synuclein.

Aptasensors for the Selective Detection of Alpha-Synuclein Oligomer by Colorimetry, Surface Plasmon Resonance and Electrochemical Impedance Spectroscopy

Differential Amperometric Microneedle Biosensor for Wearable Levodopa Monitoring of Parkinson's Disease

Polythionine and gold nanostar-based impedimetric aptasensor for label-free detection of α-synuclein oligomers

Nanozyme-based cascade SPR signal amplification for immunosensing of nitrated alpha-synuclein

Binding-Triggered Hybridization Chain Reaction Cascade Muti-site Activated CRISPR/Cas12a Signal Amplification Strategy for Sensitive Detection of α-Synuclein

Highly sensitive biosensor based on IGZO thin-film transistors for detection of Parkinson's disease

A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson's Disease Biomarker

Chitosan-enhanced sensitivity of mercaptoundecanoic acid (MUA)- capped gold nanorod based localized surface plasmon resonance (LSPR) biosensor for detection of alpha-synuclein oligomer biomarker in parkinson's disease

LoC-SERS Platform Integrated with the Signal Amplification Strategy toward Parkinson's Disease Diagnosis

An innovative method for the detection of synuclein alpha, a potential biomarker of Parkinson's disease: Quartz tuning fork-based mass sensitive immunosensor design

Pain-Free Alpha-Synuclein Detection by Low-Cost Hierarchical Nanowire Based Electrode

Alpha‐Synuclein Oligomers Driven T1‐T2 Switchable Nanoprobes for Early and Accurate Diagnosis of Parkinson's Disease

Liposomal Controlled Release Ag-Activated DNAzyme Cycle Amplification on a 2D Pyrene COF-Based Photocathode for α-Synuclein Immunosensing

Freestanding Nanofiber‐Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers

Submonolayer Biolasers for Parkinson’s Disease Biomarker Detection

Magneto-assisted enzymatic DNA walkers for simultaneous electrochemical detection of amyloid-beta oligomers and Tau

Poly-Adenine Assisted Signaling Displaced Probe Ratiometric Electrochemical Aptasensor for Accurate Detection of Alzheimer's Disease Aβ Biomarkers

Polydopamine functionalized dendritic fibrous silica nanoparticles as a generic platform for nucleic acid-based biosensing

In-situ nanozyme catalytic amplification coupled with a universal antibody orientation strategy based electrochemical immunosensor for AD-related biomarker